Assessment of association efficacy of colinergic precursor and cholinesterasic inhibitor somministered transdermal in patient with Alzheimer`s disease and severe behavioural disturbances

Trial Profile

Assessment of association efficacy of colinergic precursor and cholinesterasic inhibitor somministered transdermal in patient with Alzheimer`s disease and severe behavioural disturbances

Recruiting
Phase of Trial: Phase II

Latest Information Update: 22 Mar 2012

At a glance

  • Drugs Choline alfoscerate (Primary) ; Acetylcholinesterase inhibitors
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Acronyms ASCOTALCO
  • Most Recent Events

    • 22 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top